We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
An artificially intelligent web-based app for stock market investors to potentially increase their returns. Butterwire's platform aims to solve three common challenges more than 1 million UK investors face: finding high-return opportunities, minimising risk and being aware of sudden market fluctuations.
days to go: Expired investment: Withheld
Vendoir is an all-in-one event planning app with a mission to create sustainable, stress-free, and inclusive events. Launched publicly in November 2022, it offers convenient access to event suppliers and management. The goal is to build a global, diverse, and sustainable community for seamless event planning, especially catering to digital natives. With the UK event industry valued at £70 billion, Endoir sees substantial growth potential. Committed to achieving net-zero carbon emissions by 2040, the platform aims to reduce emissions by enabling remote supplier sourcing. It also plans to introduce a secondary marketplace to minimize waste and a tool for tracking event carbon footprints to support sustainability. Endoir is a cutting-edge marketplace that features vetted suppliers, secure transactions, and reliable reviews. They provide a comprehensive event planning solution and have future plans for AI-driven efficiency improvements. Upcoming app features include customer pricing, an expense-sharing solution, and a fan page for suppliers.
days to go: Expired investment: £114,896
Fitbakes is a low sugar and high protein baked snacks brand. The company claims that its products have 90% less sugar, 80% less fat, 60% fewer calories and 200% more protein than leading cakes and chocolate brands with no artificial sweeteners, flavourings or colourings. Fitbakes claims that its products are compliant with the UK government's 'Non-HFSS' policy. The company has sold over 1 million cakes via the 'Direct 2 Consumer' channel, experienced 25% repeat purchase in-store, onboarded retailers such as Coop and Selfridges, and planned a launch in 1,000 Tesco Express stores in Q3 2021. The company is also working with over 1,000 micro-influencers and over 50,000 Instagram followers. It was also a winner at the 'Best of Health Awards' and a finalist at the 'MidCounties Good Food Awards'. The company has received press coverage in BBC1 News, The Times, Forbes, The Telegraph, Daily Mail and The Grocer. It states it will use the investment to support its digital growth and retail launch with major retailers.
days to go: Expired investment: £523,184
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £286,096
United Medicine have created a platform where experience, knowledge and opinion of their medical users is used to provide a global consensus and allows the good evidence to be separated from the bad.   
days to go: Expired investment: £152,000
East London Liquor Company (ELLC) has been distilling, importing and serving gins, whiskies, vodkas, rums, and canned cocktails since 2014. ELLC asserts that off-trade gin sales hit US$8.4 billion in 2020 with UK seltzer sales expected to reach £75 million by 2023. It intends to become a contender in the aforementioned categories. ELLC has had a 600% Year-on-Year (YoY) increase to £206,000 in off-trade sales from 2019-2020 to 2020-2021. The company has partnered with the UNESCO world heritage site, Royal Botanic Gardens, Kew, to release its product, Kew Gin. It has also entered into the Ready-To-Drink and seltzer categories with its range of canned drinks, and onboarded retailers like Waitrose, Tesco, and Co-Op. The company will use the investment to grow its off-trade channels both in the UK and abroad, expand its Direct To Consumer (DTC) output, update its 'Brand Home' to attract more customers, and increase its whisky production to meet demand.
days to go: Expired investment: £921,686
Knoma is a payment solution that helps people looking to future-proof their career or move into new areas of work by eliminating the burden of upfront payment, and by removing the challenges of sourcing an appropriate course. Backed by a large European Venture Capital firm, Knoma enables lifelong learning as the global economy transitions to one where digital skills are essential for career success. All Knoma students can gain access up to £10,000 to pay for the course of their choice, which can be spread over 12 months with flexible repayments with no interest or fees applicable. The company has partnered with organisations like Codeclan, Wild Code School, Le Wagon, and Code Nation and has successfully secured £750,000 in funding from some of Europe's largest venture capital firms, namely, Global Founders Capital, and Rocket Internet. The company will utilise the investments to expand partnerships with tech and coding schools, test and deploy the Knoma app, unlock a £20 million debt facility to provide Knoma loans to its students, and scale the business on all verticals.
days to go: Expired investment: £529,660
Bird and Blend Tea (BABT) is a British independent tea mixologist. The company claims to offer 100+ blends of tea in a vegan-friendly product range, employs 125+ people and runs a global e-commerce platform attracting 100,000 monthly users. It claims to have achieved a £3.97 million turnover in 2020-2021 despite lockdown closures of its retail stores. BABT asserts that it operates 13 experiential retail stores across the UK since its last crowdfund in 2017. It has also featured in press entities such as The Independent, OK!, Huff Post, The Telegraph, and GQ Magazine. The company states it will use the investment to expedite the growth of its brand with investments in digital innovation, develop its technology stack, strengthen its team, open more multisensory stores, and undertake impactful projects to achieve B Corp status.
days to go: Expired investment: £999,867
Rebel Energy (RE) is an energy supplier on a mission to address inequality and provide everyone with easy access to clean and affordable energy, to eventually eliminate fuel poverty. RE claims that fuel poverty led to 16,500+ cold-related deaths in the UK in 2018. RE argues that as the UK home electricity market enters a phase of growth in a post-COVID world, it will be focused on offering reliable customer service and develop strategies that help people who are struggling with their electricity bills. The company has applied for a B Corporation accreditation. RE asserts that its customer support systems are automated and can handle multiple queries simultaneously. It plans to offer a weekly direct debit payment option. RE will use the investment to grow its business across different verticals.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £503,810
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph